Summit Healthcare Acquisition Overview
Valuation check: SMIH's ROE is 18.87%, above the sector sector average of -5.93%.
Get informed when a big investor buys or sells
+ Follow18.87%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Summit Healthcare Acquisition (SMIH) currently reports a ROE of 18.87%. That is above the sector sector average of -5.93%. Use the charts on this page to explore Summit Healthcare Acquisition's ROE history and peer comparisons.
Summit Healthcare Acquisition's ROE of 18.87% is higher than the its sector sector average of -5.93%. That is roughly 418.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Summit Healthcare Acquisition's current 18.87% should be judged against industry norms (sector average: -5.93%) and against SMIH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 18.87%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.93%. From there, open related valuation or income-statement pages for Summit Healthcare Acquisition, and consider following SMIH for alerts when major investors trade the stock.
